Loading…
Based on limited metadata, this warning letter issued to Trilogy Laboratories, LLC on March 5, 2020 concerns drug product manufacturing or distribution compliance. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The FDA initiated this action within its drug regulatory authority, though the specific issuing office is not identified in the metadata provided. Additional details regarding the particular violations and required corrective actions would require review of the complete warning letter.